| |
68Ga-PSMA ligand PET versus 18F-NaF PET: evaluation of response to 223Ra therapy in a prostate cancer patient
- 作者:Christian Uprimny (1)
Alexander Kroiss (1) Bernhard Nilica (1) Sabine Buxbaum (1) Clemens Decristoforo (1) Wolfgang Horninger (2) Irene J. Virgolini (1)
1. Department of Nuclear Medicine ; Medical University Innsbruck ; Anichstrasse 35 ; Innsbruck ; Austria 2. Department of Urology ; Medical University Innsbruck ; Anichstrasse 35 ; Innsbruck ; Austria
- 刊名:European Journal of Nuclear Medicine and Molecular Imaging
- 出版年:2015
- 出版时间:February 2015
- 年:2015
- 卷:42
- 期:2
- 页码:362-363
- 全文大小:257 KB
- 参考文献:1. Parker C, Nilsson S, Heinrich D, Helle SI, O鈥橲ullivan JM, Fossa SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213鈥?3. CrossRef
2. Lawrentschuk N, Davis ID, Bolton DM, Scott AM. Diagnostic and therapeutic use of radioisotopes for bone disease in prostate cancer: current practice. Int J Urol. 2007;14(2):89鈥?5. CrossRef 3. Afshar-Oromieh A, Haberkorn U, Eder M, Eisenhut M, Zechmann C. [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH. Eur J Nucl Med Mol Imaging. 2012;39(6):1085鈥?. CrossRef 4. Van Schelven WD, Pauwels EK. The flare phenomenon: far from fair and square. Eur J Nucl Med. 1994;21(5):377鈥?0. CrossRef
- 刊物类别:Medicine
- 刊物主题:Medicine & Public Health
Nuclear Medicine Imaging and Radiology Orthopedics Cardiology Oncology
- 出版者:Springer Berlin / Heidelberg
- ISSN:1619-7089
| |
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.
| |